Results of a new study highlight the expanding role of surgical oncologists in industry-sponsored clinical trials.
According to data presented at the 2019 Society of Surgical Oncology Annual Cancer Symposium, the majority of industry research payments to surgical oncologists were related to clinical trials for novel pharmaceuticals rather than medical devices. Findings from the retrospective analysis also showed that industry payments were influenced by location, academic